AstraZeneca announces organisational changes
7 January 2019 13:00 GMT AstraZeneca announces organisational changes Company to drive innovation, focus, growth and productivity; José Baselga, MD, PhD, appointed to head R&D for Oncology AstraZeneca is today announcing organisational changes to support continued scientific innovation and commercial success in the main therapy areas as the Company enters a new phase in its strategic development. Included in the changes will be the arrival at AstraZeneca of the world-renowned oncology scientist, José Baselga, as well as the creation of: · Therapy area-focused Research and